Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Sensei Biotherapeutics(SNSE) the EBIT is -170.63 M (-2246%);the EPS is -131.45 (-2312%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.17B2245.71%
----
----
EPS
-131.45112312.10%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf